Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05518877 · ClinicalTrials.gov registry record · Phase 4
Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects
A Phase 4 study, sponsored by Summa Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 55
- Enrollment target
NCT05518877 is a Phase 4 study that has completed, run by Summa Health System. The registered enrollment target is 55 participants.
The verdict
NCT05518877, a Phase 4 study, has completed, sponsored by Summa Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 55 participants
- Enrollment target
Study Summary
This will be an intent to treat prospective, double blind, double-dummy, randomized trial. Our primary objective is the reduction of side effects of sub dissociative dose ketamine given by slow intravenous (IV) infusion over 30 minutes vs. 15 minutes in the treatment of acute, severe pain in Emergency Department (ED) patients. The secondary objective will be to maintain adequate pain control (as defined by a Visual Analog Scale (VAS) score of ≤ 5cm) at 30 minutes for both groups.
Interventions
- DRUG Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2022-12-07 |
| Est. Completion | 2025-04-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05518877
The ClinicalTrials.gov registry entry for NCT05518877 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Summa Health System, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketamine is the first listed.
NCT05518877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05518877 about?
NCT05518877 is a clinical study titled "Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects". This will be an intent to treat prospective, double blind, double-dummy, randomized trial. Our primary objective is the reduction of side effects of sub dissociative dose ketamine given by slow intravenous (IV) infusion over 30 minutes vs. 15 minutes in the treatment of acute, severe pain in Emergen...
What is the current status of trial NCT05518877?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2022-12-07. Estimated completion is 2025-04-02.
What interventions are being tested in trial NCT05518877?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT05518877?
This trial is sponsored by Summa Health System, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.